BRIEF-GSK's ViiV completes deal to buy Bristol-Myers Squibb's R&D HIV assets
February 22, 2016 at 10:58 AM EST
* Completion of both transactions follows antitrust approval by relevant regulatory authorities in US, with integration process beginning immediately
